# EDGAR Filing Document

**Accession Number:** 0000725363
**File Stem:** 0001654954-26-004538
**Filing Date:** 2026-5
**Character Count:** 1706
**Document Hash:** f6c3bab8f4be89611dad7df2082d52fc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-26-004538.hdr.sgml**: 20260610

**ACCESSION NUMBER**: 0001654954-26-004538

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260507

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CEL SCI CORP
- **CENTRAL INDEX KEY:** 0000725363
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 840916344
- **STATE OF INCORPORATION:** CO
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 8229 BOONE BLVD .
- **STREET 2:** SUITE 802
- **CITY:** VIENNA
- **STATE:** VA
- **ZIP:** 22182
- **BUSINESS PHONE:** 7035069460

**MAIL ADDRESS:**
- **STREET 1:** 8229 BOONE BLVD.
- **STREET 2:** SUITE 802
- **CITY:** VIENNA
- **STATE:** VA
- **ZIP:** 22182

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INTERLEUKIN 2 INC
- **DATE OF NAME CHANGE:** 19880317

**ThinkEquity LLC**

**17 State Street, 41<sup>st</sup> Floor**

**New York, NY 10004**

May 7, 2026

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

**Re: Cel-Sci Corporation Request for Acceleration**

**Registration Statement on Form S-1**

**File No. 333-295168 (the "Registration Statement")**

Ladies and Gentlemen:

ThinkEquity LLC ("ThinkEquity") hereby concurs in the request by the Company to withdraw its request for an acceleration of the above referenced registration statement.

---

| |
|:---|
| Very truly yours, |
| **ThinkEquity LLC** |
| */s/ Eric Lord* |
| Eric Lord |
| Head of Investment Banking |

---